Sunday 11 October 2026 Export all LLY data to Excel Powerpack

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,179.27 9.67 +0.83%
Market cap
$1.10T
P/E
39.6×
Fwd P/E
33.1×
Dividend yield
0.57%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
6,038.60 8,034.10 7,408.90 2,438.50 3,681.30 3,908.60 2,211.80 2,927.70 3,268.00 7,268.00
Receivables
4,766.30 5,262.20 5,776.80 5,541.50 6,929.00 8,127.20 8,558.90 11,336.20 13,276.00 20,155.00
Inventory
3,561.90 4,458.30 3,098.10 3,190.70 3,980.30 3,886.00 4,309.70 5,772.80 7,589.00 13,744.00
Other current assets
735.00 1,448.00 4,266.00 2,539.00 2,872.00 2,531.00 7.30 149.50 266.00 147.00
Total current assets
15,101.40 19,202.10 20,549.60 13,709.60 17,462.10 18,452.40 18,034.50 25,727.00 32,740.00 55,629.00
Property, Plant, Equpment (Net)
8,252.60 8,826.50 7,996.10 7,872.90 8,681.90 8,985.10 10,144.00 12,913.60 17,102.00 24,675.00
Long-Term Investments
5,207.50 5,678.80 2,005.40 1,962.40 2,966.80 3,212.60 2,901.80 3,052.20 3,216.00 2,802.00
Goodwill and Intangible Assets (Total)
8,330.60 8,399.30 2,434.60 10,297.40 11,216.50 11,583.90 11,279.60 11,846.30 11,936.00 12,419.00
Long Term Assets (Tax, Deferred)
— 1,166.40 2,613.70 2,572.60 2,830.40 2,489.30 2,792.90 5,477.30 8,001.00 9,959.00
Long-term assets (Other)
1,913.80 1,707.90 1,824.90 2,871.20 3,475.40 4,082.70 4,337.00 4,989.90 5,720.00 6,992.00
Total non-current assets
23,704.50 25,778.90 23,358.80 25,576.50 29,171.00 30,353.60 31,455.30 38,279.30 45,975.00 56,847.00
Total Assets
38,805.90 44,981.00 43,908.40 39,286.10 46,633.10 48,806.00 49,489.80 64,006.30 78,715.00 112,476.00
Notes Payable
1,937.40 3,706.60 1,102.20 1,499.30 8.70 1,538.30 1,501.10 6,904.50 5,117.00 1,635.00
Accounts Payable
1,349.30 1,410.70 1,207.10 1,405.30 1,606.70 1,670.60 1,930.60 2,598.80 3,229.00 5,379.00
Dividends Payable
548.10 590.60 650.80 671.50 770.60 885.50 1,017.20 1,169.20 1,346.30 —
Current Part of Debt
1,937.00 3,707.00 1,102.00 1,621.00 8.70 — — — — —
Current Part of Taxes to Pay
119.10 532.90 393.40 160.60 495.10 126.90 475.10 — — —
Other current liabilities
7,032.70 8,295.10 7,841.80 8,038.50 9,600.50 10,831.40 12,689.30 16,620.70 20,030.00 28,214.00
Total current liabilities
10,986.60 14,535.90 11,888.10 11,775.20 12,481.60 15,052.70 17,138.20 27,293.20 28,376.00 35,228.00
Long Term Debt (Total)
8,367.80 9,940.50 9,196.40 13,817.90 16,586.60 15,346.40 14,737.50 18,320.80 28,527.00 40,868.00
Pension and Post-Retirement Liabilities
2,453.90 3,513.90 2,802.20 3,698.20 4,094.50 1,954.10 1,305.10 1,438.80 1,300.50 —
Long Term Tax Liability (Deferred)
440.00 (788.00) 1,312.70 2,187.50 2,099.90 1,733.70 — — — —
Non-current Liabilities (Other)
2,917.10 5,322.80 5,057.60 5,108.20 5,545.30 5,564.30 5,533.60 6,089.80 7,540.00 9,845.00
Total non-current liabilities
13,738.80 18,777.20 21,111.20 24,811.80 28,326.30 24,598.50 21,576.20 25,849.40 36,067.00 50,713.00
Total liabilities
24,725.40 33,313.10 32,999.30 36,587.00 40,807.90 39,651.20 38,714.40 53,142.60 64,443.00 85,941.00
Additional Paid In Capital
5,640.60 5,817.80 6,583.60 6,685.30 6,778.50 6,833.40 6,921.40 7,250.40 7,439.00 7,346.00
Common Stock (Net)
688.50 687.90 661.00 598.80 598.20 596.30 594.10 593.60 592.00 590.00
Retained Earnings
16,046.30 13,894.10 11,395.90 4,920.40 7,830.20 8,958.50 10,042.60 10,312.30 13,545.00 24,470.00
Treasury Stock
80.50 75.80 69.40 60.80 55.70 52.70 50.50 44.20 49.50 —
Shareholders Equity (Other)
(3,013.20) (3,013.20) (3,013.20) (3,013.20) (3,013.20) (3,013.20) (3,013.20) (3,013.20) (2,982.00) (2,991.00)
Common Equity (Total)
14,080.50 11,667.90 10,909.10 2,699.10 5,825.20 9,154.80 10,775.40 10,863.70 14,272.00 26,535.00
Shareholders Equity (Total)
14,080.50 11,667.90 10,909.10 2,699.10 5,825.20 9,154.80 10,775.40 10,863.70 14,272.00 26,535.00
Shareholders Equity and Liabilities (Total)
38,805.90 44,981.00 43,908.40 39,286.10 46,633.10 48,806.00 49,489.80 64,006.30 78,715.00 112,476.00
Shares (Common)
1,100.88 1,100.01 1,057.04 957.53 956.59 953.65 950.18 949.38 947.90 944.80
Shareholders Equity (Tangible)
5,749.90 3,268.60 8,474.50 (7,598.30) (5,391.30) (2,429.10) (504.20) (982.60) 2,336.00 14,116.00
Net Debt
4,266.20 5,613.40 2,889.50 13,000.40 12,914.00 11,437.80 12,525.70 15,393.10 25,259.00 33,600.00
Total Debt
10,304.80 13,647.50 10,298.40 15,438.90 16,595.30 15,346.40 14,737.50 18,320.80 28,527.00 40,868.00

Fold the line items

In millions of $ except per-share values · columns are period end dates